Prestige Consumer Healthcare Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Prestige Consumer Healthcare Inc in the first quarter 2026?
Prestige Consumer Healthcare Inc achieved a return on average equity (ROE) of 21.77 % in its first quarter 2026, this is above PBH's average return on equity of 18.25%.
Prestige Consumer Healthcare Inc shareholder's equity over the 12 months ending in its first quarter 2026 are valued at $1,866 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Major Pharmaceutical Preparations industry 33 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2026 from 424 to 533.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Equity Change	3.3 %	2.87 %	10.86 %	5.38 %	-
Y / Y Net Income Change	-38.01 %	-4.34 %	-23.14 %	-11.66 %	1.64 %
Net Income (TTM) in Millions	406	448	453	486	501
Return On Equity (TTM)	21.77 %	24.2 %	24.66 %	27.1 %	28.29 %
PBH's Total Ranking	# 533	# 424	# 403	# 370	# 334
Equity (TTM) in Millions	1,917	1,888	1,835	1,825	1,855
Seq. Equity Change	1.55 %	2.87 %	0.54 %	-1.64 %	1.12 %
Seq. Net Income Change	-42.95 %	9.39 %	-2.55 %	1.92 %	-11.96 %

Back to PBH Management Effectiveness >> PBH's 5 Years Annual ROE >> Compare PBH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 34
Sector	# 77
Overall	# 533

Return On Equity Statistics
High	Average	Low
58.51 %	18.25 %	-5.65 %
(Dec 31 2017)		(Jun 30 2023)

PBH Annual Return On Equity	(Mar 31 2026) 2026	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2022) 2022
Total Equity in Millions	1,888	1,835	1,655	1,447	1,578
Y / Y Equity Change	2.87 %	10.86 %	14.37 %	-8.27 %	16.15 %
Net Income in Millions	448	499	485	-82	205
Y / Y Net Income Change	-10.22 %	2.77 %	-	-	24.71 %
Return On Equity	23.72 %	27.18 %	29.33 %	-5.69 %	13.02 %

Back to PBH Management Effectiveness >> PBH's 5 Years Annual ROE >> Compare PBH ROE to its Competitors

Annual Roe Comment

In 2026 ROE decreased compared to the previous year to 23.72 %, due to deterioration of net income.

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PBH's' Return on Equity at Yahoo Finance
PBH's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PBH's Competitors
Subscribers only: Roe for Prestige Consumer Healthcare Inc 's Suppliers
Subscribers only: Return On Equity for PBH's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Aurinia Pharmaceuticals Inc	59.00 %
Vaxart Inc	53.04 %
Qhslab Inc	51.21 %
Tenet Healthcare Corp	50.64 %
Nrc Health	48.29 %
Concentra Group Holdings Parent Inc	48.13 %
Bristol myers Squibb Company	46.65 %
Agilent Technologies inc	41.99 %
Eton Pharmaceuticals Inc	40.13 %
Adma Biologics Inc	39.59 %
Dexcom Inc	36.25 %
Transmedics Group Inc	33.37 %
Arcutis Biotherapeutics Inc	32.92 %
Caredx Inc	32.81 %
Zevra Therapeutics Inc	32.56 %
Acadia Pharmaceuticals Inc	32.39 %
Pro dex Inc	31.96 %
Protalix Biotherapeutics inc	31.61 %
Illumina Inc	31.08 %
Innoviva Inc	30.03 %
Phibro Animal Health Corporation	29.66 %
Chemed Corporation	29.45 %
Solventum Corporation	28.96 %
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %

Date modified: 2026-09-26T06:52:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.